Developments, news and strategies for drug development specific to phase I through Phase III global clinical trial management, execution, project management and outsourcing. Go→
News, articles and issues specific to clinical trial practice and implementation at the investigative site level. Go→
Strategies and innovations related to how clinical professionals are utilizing technology internal and external to their organizations to advance clinical trials. Go→
News, articles and issues specific to laboratories role in the clinical trial, including ECG, imaging, genotyping, tissue samples and more. Go→
News, developments and strategies for clinical trials conduct in relation to the FDA, EMEA and other global regulatory authorities overseeing the drug development industry. Go→
News, articles and strategies related to clinical trial design which impact postmarketing studies, therapeutic areas, adaptive trials, statistics, protocols and more. Go→
Clinipace Worldwide, a global digital clinical research organization (dCRO), announced today the company has closed its strongest year to date, with a record number of new clinical development projects and regulatory and strategic development engagements; driving 114% growth in bookings compared to the previous year.
“The continued growth in both new client acquisition and follow-on projects from existing clients demonstrates the level of trust and partnership we build with our clients,” said Jeff Williams, Clinipace Worldwide Founder and CEO. “We work hard to forge a real partnership with our clients and to provide efficiency and visibility into study and program management through our dCRO model.”
Clinipace also experienced solid growth in several therapeutic areas over the past year including oncology/hematology, infectious disease, gastroenterology, cardiovascular, nephrology, immunology, pediatrics, and women’s health. The company’s depth and breadth of expertise managing oncology clinical trials remains one of its strongest core competencies.
Clinipace hired 50 net new team members in 2013, and expects to expand by an additional 25% in 2014 to support continued growth. Areas of aggressive hiring included clinical monitoring, site management services, clinical project management, clinical data management, and financial operations.
Clinipace Worldwide was recognized this past year both regionally and nationally for its tremendous growth with several prestigious business awards. The company started off the year on a high note, ranking #36 in FORBES’ list of America’s 100 Most Promising Companies. In May, the Triangle Business Journal and accounting giant BDO honored Clinipace with one of its inaugural Life Sciences Awards. The company also was named to Inc. Magazine’s Inc. 500, upon generating a three-year growth rate of 918.55% from 2010 to 2012. This is the fourth consecutive year that Clinipace Worldwide has been recognized—an honor bestowed to few other companies in the nation. Clinipace was recognized for the fourth year in a row as one of the 50 fastest growing private companies in the Triangle at the Triangle Business Journal’s Fast 50 Awards. Clinipace also received the distinction of being chosen as an Inc. Magazine Hire Power Awards winner. Clinipace ranked 67th overall, placing it among the top 100 private business job creators in the country, 2nd in private business job creators within North Carolina, and 7th within the health industry.